Navigation Links
Biomira Announces Plan to Reincorporate in the United States
Date:9/12/2007

an of arrangement and the shares to be issued to Biomira's shareholders in the plan of arrangement. Assuming that the SEC declares the registration statement effective, the shareholders approve of the plan of arrangement, and the Alberta Court of Queen's Bench issues a final order approving the plan of arrangement, Biomira currently estimates that the transactions contemplated by the plan of arrangement should be completed in early 2008.

About Biomira

Biomira is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Biomira's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients.

Conference Call and Webcast

Biomira's management will hold a conference call beginning at 10:00 a.m. EDT today, September 12, 2007. To listen to a live webcast of the call, visit http://www.biomira.com. Biomira intends to make a recording of the webcast available on the Biomira website and via telephone replay. It is expected that the archive of the webcast will be available approximately 15 minutes after completion of the discussion and will be posted for 90 days. It is expected that a replay will be available by phone approximately one hour after completion of the discussion and will be accessible for 7 days. Access numbers for this replay are:

416-640-1917, passcode 21246399 followed by the pound sign or

877-289-8525, passcode 21246399 followed by the pound sign

Forward Looking Statements

In order to provide Biomira's investors with an understanding of its current intentions and future prospects, this release contains statements that are forward looking, including statements relating to the anticipated benefits of the proposed reincorporation of Biomira from Canada to the United States. These forward-looking state
'/>"/>

SOURCE Biomira Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Telbec/ - Mirego, leader in mobile strategies and solutions, is ... app extensions for the all new Apple Watch. Made in ... and MediaMiser, these extensions will reinvent the way users receive ... wrist use.  Available today in ... tactile smartwatch that makes for an excellent buddy for business, ...
(Date:4/23/2015)... Athena San Diego, an organization that ... in San Diego’s technology and life science sectors, will ... at their Gala on April 30, 2015 from 5-9pm ... http://athenasd.org/events/ , The Pinnacle Awards recognize individuals ... vision of fostering networking, risk taking and diversity of ...
(Date:4/23/2015)... , April 23, 2015  Neurocrine Biosciences, Inc. ... will report its first quarter 2015 results before the ... will then host a live conference call and webcast to ... Thursday morning, April 30, 2015 at 8:00 a.m. Eastern ... access the live conference call by dialing 866-952-1906 (US) ...
(Date:4/23/2015)... LONDON , April 23, 2015 ... Medical Equipment   Report Details   ... reach a value of $101.3 billion in 2015 and will ... Strong growth in the healthcare sectors around the world and ... the key growth factors in the global healthcare packaging ...
Breaking Biology Technology:Familiprix, OMSignal and MediaMiser apps available today for Apple Watch 2Athena Pinnacle Awards to Honor Executives, Corporations and Educators Working to Promote Women Leaders 2Neurocrine Biosciences Announces Conference Call and Webcast to Report First Quarter 2015 Results 2Healthcare Packaging Market Forecast 2015-2025 2Healthcare Packaging Market Forecast 2015-2025 3Healthcare Packaging Market Forecast 2015-2025 4Healthcare Packaging Market Forecast 2015-2025 5Healthcare Packaging Market Forecast 2015-2025 6Healthcare Packaging Market Forecast 2015-2025 7Healthcare Packaging Market Forecast 2015-2025 8Healthcare Packaging Market Forecast 2015-2025 9Healthcare Packaging Market Forecast 2015-2025 10
... , NEW YORK , ... NBS ) ("NeoStem" or the "Company"), an international,biopharmaceutical ... , today,announced that it has been awarded a ... Materiel Command, Telemedicine and Advanced Technology,Research Center (USAMRMC-TATRC) under ...
... July 12 Alaska Airlines (NYSE: ... International Airport, Seattle-Tacoma International Airport, Spokane International ... strategic initiative to promote aviation biofuel development in the Pacific ... the United States , the "Sustainable Aviation Fuels Northwest" project ...
... , , ... /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical ... formation of an international clinical advisory panel (the "Panel"). , ... This Panel of international experts with special expertise in ovarian ...
Cached Biology Technology:NeoStem to Receive $700,000 from the U.S. Army's Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds 2NeoStem to Receive $700,000 from the U.S. Army's Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds 3NeoStem to Receive $700,000 from the U.S. Army's Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds 4NeoStem to Receive $700,000 from the U.S. Army's Medical Research and Materiel Command to Advance Adult Stem Cell Therapies in Treating Traumatic Wounds 5Transportation and Aviation Leaders Launch Sustainable Biofuels Initiative 2Transportation and Aviation Leaders Launch Sustainable Biofuels Initiative 3Quest PharmaTech Announces Formation of Clinical Advisory Panel 2Quest PharmaTech Announces Formation of Clinical Advisory Panel 3
(Date:4/10/2015)... , April 10, 2015 Research ... of the "Security Competitive Profiles - NEC" ... , NEC will continue to supply a ... the market, with a company focus on the development ... Winning opportunities in the Asia-Pacific ...
(Date:4/6/2015)... OXFORD, Conn. , Apr. 6, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... it has filed provisional patent 62/143028 for ... CLOSE-PROXIMITY COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces ... wireless payments. This patent surrounds the use of ...
(Date:4/2/2015)... GOTHENBURG, Sweden , April 2, 2015 ... revenues for Q1 2015 attributed to somewhat higher than ... company in the year-end report 2014 that revenues for ... MSEK that the company reported for Q4 2014. The ... continue to be negative. The complete interim report will ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4Fingerprint Cards Revises Revenues for Q1 2015 2
... Patients with type 1 diabetes who used continuous ... experienced significant improvements in blood sugar control, according to ... by the Juvenile Diabetes Research Foundation. Results from the ... the Study of Diabetes (EASD) annual meeting in Rome, ...
... The American College of Clinical Pharmacology (ACCP) has ... PhD , director of Pediatric Clinical Pharmacology at ... Award. Dr. van den Anker, a neonatologist ... and prolific contributions to pediatric clinical pharmacology," according ...
... the choice all too frequently has come down to ... trigger indoor allergens. Today, The Clorox Company extends ... Anywhere® Anti-Allergen Fabric Spray, a new product to help ... Clorox® Anywhere® Anti-Allergen Fabric Spray denatures dust ...
Cached Biology News:JDRF-funded clinical trial demonstrates continuous glucose monitoring improves blood sugar control 2JDRF-funded clinical trial demonstrates continuous glucose monitoring improves blood sugar control 3The Clorox Company's new indoor allergen product reduces common indoor allergens up to 90 percent 2
... Services is a microarray ... industrial and academic researchers. We ... of Agilent, and we provide ... Agilent catalogue arrays. Gene ...
Immunogen GST fusion protein corresponding to full-length rat JNK3/ SAPK1b. Quality Assurance Routinely evaluated by immunoblot. Stability 2 years at -20°C from date of shipment GenBank A...
... post-translational modification that plays an important ... regulation, inflammation, cell-to-cell adhesion, and cell ... lectin based Glycoprotein Isolation Kits, Concanavalin ... (WGA), that allow isolation of glycoproteins ...
... series of laser scanners is the starting ... solution. ,Gene expression analysis, SNP (Single ... essential to the advancement of research in ... novel microarray formats and sizes. These arrays ...
Biology Products: